Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Investigative Dermatology|June 6, 2003
Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation modelChristiane Thallinger, Markus F Wolschek, Volker Wacheck, et al.
Plos Currents|March 2, 2012
Phylogenetic discordance of human and canine carcinoembryonic antigen (CEA, CEACAM) families, but striking identity of the CEA receptors will impact comparative oncology studiesMarlene Weichselbaumer, Michael Willmann, Martin Reifinger, et al.
Cancer Research|April 4, 2002
The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanomaEdgar Selzer, Volker Wacheck, Trevor Lucas, et al.
Oncotarget|September 27, 2019
Correction: Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancerMohamed A Ahmed, Edgar Selzer, Wolfgang Dörr, et al.
Oncotarget|September 22, 2016
Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancerMohamed A Ahmed, Edgar Selzer, Wolfgang Dörr, et al.
Blood|November 16, 2002
The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockadePeter Blaha, Sinda Bigenzahn, Zvonimir Koporc, et al.
Neurobiology of Disease|September 25, 2007
Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous systemRoland Grundtner, Klaus Dornmair, Ralf Dahm, et al.
Blood|November 18, 2006
Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412Karl J Aichberger, Matthias Mayerhofer, Karoline V Gleixner, et al.
Cancer Research|May 6, 2004
Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemiaMatthias Mayerhofer, Stefan Florian, Maria-Theresa Krauth, et al.
Cancer Research|October 19, 2005
Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compoundsKarl J Aichberger, Matthias Mayerhofer, Maria-Theresa Krauth, et al.
Pageof 8